SB1317

SB1317 Suppliers list
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  
Tel: 17702719238
Email: sales@sun-shinechem.com
Company Name: Dalian Meilun Biotech Co., Ltd.  
Tel: 0411-62910999 13889544652
Email: sales@meilune.com
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: Shanghai Aladdin Bio-Chem Technology Co.,LTD  
Tel: 400-6206333 13167063860
Email: anhua.mao@aladdin-e.com

SB1317 manufacturers

SB1317 Basic information
Product Name:SB1317
Synonyms:TG-02/SB-1317;14-Methyl-20-oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene;SB1317, >=98%;SB1317(TG-02) hydrochloride;CS-915;TG02; SB 1317; TG 02; SB-1317; TG-02;TG02;TG-02;20-Oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-
CAS:937270-47-8
MF:C23H24N4O
MW:372.46
EINECS:
Product Categories:
Mol File:937270-47-8.mol
SB1317 Structure
SB1317 Chemical Properties
Boiling point 575.5±60.0 °C(Predicted)
density 1.16±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility insoluble in H2O; ≥44.87 mg/mL in DMSO; ≥3.98 mg/mL in EtOH with gentle warming and ultrasonic
form solid
pka8.03±0.20(Predicted)
color Off-white to light yellow
Safety Information
MSDS Information
SB1317 Usage And Synthesis
UsesTG 02 is a cyclin dependent kinase inhibitors (CDK inhibitors) for the treatment of chronic lymphocytic leukemia.
in vivo

(E/Z)-Zotiraciclib (50 and 75 mg/kg; p.o. once daily for 3 weeks) inhibits tumor growth[1]. (E/Z)-Zotiraciclib (15 and 75 mg/kg; p.o. once daily 2 days on and 5 days off; i.p. once daily 5 days on 5 days off) inhibits tumor growth in two manners[1].

Animal Model:Male BALB/c mice with HCT-116 colon cancer cells xenografts[1]
Dosage:50 and 75 mg/kg
Administration:Oral gavage; 50 and 75 mg/kg once daily for 3 weeks
Result:Significantly inhibited the growth of tumors with a mean TGI of 82%.
Animal Model:Male BALB/c mice with lymphoma Ramos cells xenografts[1]
Dosage:15 and 75 mg/kg
Administration:Oral gavage and intraperitoneal injection ; 75 mg/kg once daily 2 days on and 5 days off (p.o.) and 15 mg/kg once daily 5 days on 5 days off (i.p.)
Result:Significantly inhibited the growth of tumors with mean TGIs of 42% and 63% for the oral and ip delivery methods, respectively.
IC 50CDK2: 13 nM (IC50); JAK2: 73 nM (IC50); FLT3: 56 nM (IC50)
SB1317 Preparation Products And Raw materials
Tag:SB1317(937270-47-8) Related Product Information
SB-649868 SB 204741 SB216763 Sb-742457 MMP-2/MMP-9 INHIBITOR IV SB 242084 (hydrochloride) SB 415286 SB 202190 SB 431542 5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime 6-[2-tert-Butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline SB-705498 SB 203580 SB242235 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride Zotiraciclib 4'-Chloro-3-methoxycinnamanilide SB 269970 hydrochloride